Unknown

Dataset Information

0

CD36/Sirtuin 1 Axis Impairment Contributes to Hepatic Steatosis in ACE2-Deficient Mice.


ABSTRACT: Background and Aims. Angiotensin converting enzyme 2 (ACE2) is an important component of the renin-angiotensin system. Since angiotensin peptides have been shown to be involved in hepatic steatosis, we aimed to evaluate the hepatic lipid profile in ACE2-deficient (ACE2-/y) mice. Methods. Male C57BL/6 and ACE2-/y mice were analyzed at the age of 3 and 6 months for alterations in the lipid profiles of plasma, faeces, and liver and for hepatic steatosis. Results. ACE2-/y mice showed lower body weight and white adipose tissue at all ages investigated. Moreover, these mice had lower levels of cholesterol, triglycerides, and nonesterified fatty acids in plasma. Strikingly, ACE2-/y mice showed high deposition of lipids in the liver. Expression of CD36, a protein involved in the uptake of triglycerides in liver, was increased in ACE2-/y mice. Concurrently, these mice exhibited an increase in hepatic oxidative stress, evidenced by increased lipid peroxidation and expression of uncoupling protein 2, and downregulation of sirtuin 1. ACE2-/y mice also showed impairments in glucose metabolism and insulin signaling in the liver. Conclusions. Deletion of ACE2 causes CD36/sirtuin 1 axis impairment and thereby interferes with lipid homeostasis, leading to lipodystrophy and steatosis.

SUBMITTER: Nunes-Souza V 

PROVIDER: S-EPMC5215286 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

CD36/Sirtuin 1 Axis Impairment Contributes to Hepatic Steatosis in ACE2-Deficient Mice.

Nunes-Souza Valéria V   Alenina Natalia N   Qadri Fatimunnisa F   Penninger Josef M JM   Santos Robson Augusto S RA   Bader Michael M   Rabelo Luiza A LA  

Oxidative medicine and cellular longevity 20161222


<i>Background and Aims</i>. Angiotensin converting enzyme 2 (ACE2) is an important component of the renin-angiotensin system. Since angiotensin peptides have been shown to be involved in hepatic steatosis, we aimed to evaluate the hepatic lipid profile in ACE2-deficient (ACE2<sup>-/y</sup>) mice. <i>Methods</i>. Male C57BL/6 and ACE2<sup>-/y</sup> mice were analyzed at the age of 3 and 6 months for alterations in the lipid profiles of plasma, faeces, and liver and for hepatic steatosis. <i>Resul  ...[more]

Similar Datasets

| S-EPMC3886662 | biostudies-literature
| S-EPMC9679335 | biostudies-literature
| S-EPMC8620754 | biostudies-literature
2022-11-19 | GSE197746 | GEO
| S-EPMC3793603 | biostudies-literature
| S-EPMC9579716 | biostudies-literature
| S-EPMC3771820 | biostudies-literature
| S-EPMC2773516 | biostudies-literature
| S-EPMC2587176 | biostudies-literature
| S-EPMC5742869 | biostudies-literature